Evidence map›Paper›PMID 41472014›Full record

ArticleMicroorganisms2025

Combination Therapy with Azithromycin and

Cai-Yun Wang, Meng-Yue Zhang, Hai-Ying Zhang, Yi-Meng Yang, Lu Zhang, Yi-Xuan Zhang

Abstract read
In one paragraph

Article in Microorganisms, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Cai-Yun WangSchool of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang 110016, China.
Meng-Yue ZhangSchool of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang 110016, China.
Hai-Ying ZhangFood Science and Engineering College, Beijing University of Agriculture, Beijing 102206, China.
Yi-Meng YangSchool of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang 110016, China.
Lu ZhangHangzhou Grand Biologic Pharmaceutical Inc., Hangzhou 100096, China.
Yi-Xuan ZhangSchool of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang 110016, China.ORCID 0000-0003-4849-3660

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Most probiotics require separate administration from antibiotics due to sensitivity issues.

Indexed as

azithromycinClostridium butyricuminfectious diarrheaintestinal microbiotametabolomics

Identifiers

PMID41472014
PMCPMC12736042

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.